BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2601-2612
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2601
Figure 2
Figure 2 EnVision immunohistochemical staining for adenocarcinoma. A: Positive expression of ROR2 in highly differentiated adenocarcinoma (AC); B: Negative expression of ROR2 in highly differentiated AC; C: Positive expression of WNT5a in highly differentiated AC; D: Negative expression of WNT5a in poorly differentiated AC. A and C: × 200; B and D: × 400.


Write to the Help Desk